Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma | Zendy

Åsa Ingvar | Zendy; Karin E. Smedby | Zendy; B Lindelöf | Zendy; Pia Fernberg | Zendy; Rino Bellocco | Zendy; Gunnar Tufveson | Zendy; Petter Höglund | Zendy; Johanna Adami | Zendy

Open Access

Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma

Author(s) -

Åsa Ingvar,

Karin E. Smedby,

B Lindelöf,

Pia Fernberg,

Rino Bellocco,

Gunnar Tufveson,

Petter Höglund,

Johanna Adami

Publication year - 2009

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfp425

Subject(s) - medicine , transplantation , azathioprine , cohort , organ transplantation , population , cohort study , gastroenterology , disease , environmental health

The risk of cutaneous squamous cell carcinoma (CSCC) is found to be substantially increased after organ transplantation. The association with specific immunosuppressive regimens has been previously investigated, but results are not concordant. We aimed to clarify the relationship between separate immunosuppressive drugs, drug load, timing and risk of post-transplant CSCC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research